COVID-19: viral characterization, pathophysiology and prevention

Authors

DOI:

https://doi.org/10.33448/rsd-v9i9.7768

Keywords:

SARS-CoV-2; Severe Acute Respiratory Syndrome; Pandemics.

Abstract

Introduction: There are seven known species of human coronavirus capable of causing respiratory diseases. The most recent is SARS-CoV-2, the etiologic agent of COVID-19. Objective: To evaluate the main characteristics of SARS-CoV-2, the pathophysiology of COVID-19 and the main measures for prevention and containment of disease progression. Methods: An integrative review was carried out between 2003 and 2020, based on: PubMed, Medline, SciELO, LILACS and Google Academic, using the descriptors: COVID-19, coronavirus, novel coronavirus, human, SARS virus, outbreak disease, viral pneumonia, all listed in MESH and DECS. Results: Of the 65 selected articles, 28 met the inclusion criteria. Conclusion: SARS-CoV-2 is an RNA virus whose protein S is involved in adsorption to the target cell membrane. It is transmitted through contact with contaminated surfaces, secretions or aerosols. In these, it remains viable for three hours, and up to three days on surfaces. Frequent hand washing, disinfecting surfaces, not sharing personal items, social distance of two meters and wearing facemasks when leaving home are recommended. Non-severe patients should be isolated at home for 14 days. Healthcare professionals should use PPE and be careful with potential sources of contamination, including urine and feces of patients during hygiene.

References

Brazil. (2020a). Manejo clínico e tratamento. Recuperado de https://coronavirus.saude .gov.br/manejo-clinico-e-tratamento

Brazil. (2020b). Sobre a doença. Recuperado de https://coronavirus.saude.gov.br/sobre-a-doenca#como-se-proteger

Chen, I.-Y., Moriyama, M., Chang, M.-F., & Ichinohe, T. (2019). Severe Acute Respiratory Syndrome Coronavirus Viroporin 3a Activates the NLRP3 Inflammasome. Frontiers in Microbiology, 10, 50. https://doi.org/10.3389/fmicb.2019.00050

Chen, L., Liu, W., Zhang, Q., Xu, K., Ye, G., Wu, W., Sun, Z., Liu, F., Wu, K., Zhong, B., Mei, Y., Zhang, W., Chen, Y., Li, Y., Shi, M., Lan, K., & Liu, Y. (2020). RNA based mNGS approach identifies a novel human coronavirus from two individual pneumonia cases in 2019 Wuhan outbreak. Emerging Microbes & Infections, 9(1), 313–319. https://doi.org/10.1080/22221751.2020.1725399

Corman, V. M., Lienau, J., & Witzenrath, M. (2019). [Coronaviruses as the cause of respiratory infections]. Der Internist, 60(11), 1136–1145. https://doi.org/10.1007/s00108-019-00671-5

Cui, J., Li, F., & Shi, Z.-L. (2019). Origin and evolution of pathogenic coronaviruses. Nature Reviews. Microbiology, 17(3), 181–192. https://doi.org/10.1038/s41579-018-0118-9

Galván Casas, C., Català, A., Carretero Hernández, G., Rodríguez‐Jiménez, P., Fernández‐Nieto, D., Rodríguez‐Villa Lario, A., Navarro Fernández, I., Ruiz‐Villaverde, R., Falkenhain‐López, D., Llamas Velasco, M., García‐Gavín, J., Baniandrés, O., González‐Cruz, C., Morillas‐Lahuerta, V., Cubiró, X., Figueras Nart, I., Selda‐Enriquez, G., Romaní, J., Fustà‐Novell, X., & García‐Doval, I. (2020). Classification of the cutaneous manifestations of COVID19: a rapid prospective nationwide consensus study in Spain with 375 cases. British Journal of Dermatology, 183(1), 71–77. https://doi.org/10.1111/bjd.19163

Hoffmann, M., Kleine-Weber, H., Schroeder, S., Krüger, N., Herrler, T., Erichsen, S., Schiergens, T. S., Herrler, G., Wu, N.-H., Nitsche, A., Müller, M. A., Drosten, C., & Pöhlmann, S. (2020). SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Cell, 181(2), 271-280.e8. https://doi.org/10.1016/j.cell.2020.02.052

Ianiro, G., Mullish, B. H., Kelly, C. R., Sokol, H., Kassam, Z., Ng, S. C., Fischer, M., Allegretti, J. R., Masucci, L., Zhang, F., Keller, J., Sanguinetti, M., Costello, S. P., Tilg, H., Gasbarrini, A., & Cammarota, G. (2020). Screening of faecal microbiota transplant donors during the COVID-19 outbreak: suggestions for urgent updates from an international expert panel. The Lancet. Gastroenterology & Hepatology, 5(5), 430–432. https://doi.org/10.1016/S2468-1253(20)30082-0

Jiang, S., Du, L., & Shi, Z. (2020). An emerging coronavirus causing pneumonia outbreak in Wuhan, China: calling for developing therapeutic and prophylactic strategies. Emerging Microbes & Infections, 9(1), 275–277. https://doi.org/10.1080/22221751.2020.1723441

Jin, Y., Yang, H., Ji, W., Wu, W., Chen, S., Zhang, W., & Duan, G. (2020). Virology, Epidemiology, Pathogenesis, and Control of COVID-19. Viruses, 12(4). https://doi.org/10.3390/v12040372

Kampf, G., Todt, D., Pfaender, S., & Steinmann, E. (2020). Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents. The Journal of Hospital Infection, 104(3), 246–251. https://doi.org/10.1016/j.jhin.2020.01.022

Letko, M., Marzi, A., & Munster, V. (2020). Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses. Nature Microbiology, 5(4), 562–569. https://doi.org/10.1038/s41564-020-0688-y

Li, H., Zhou, Y., Zhang, M., Wang, H., Zhao, Q., & Liu, J. (2020). Updated Approaches against SARS-CoV-2. Antimicrobial Agents and Chemotherapy, 64(6). https://doi.org/10.1128/AAC.00483-20

Lippi, G., & Plebani, M. (2020). The novel coronavirus (2019-nCoV) outbreak: think the unthinkable and be prepared to face the challenge. Diagnosis (Berlin, Germany), 7(2), 79–81. https://doi.org/10.1515/dx-2020-0015

Long, Q.-X., Liu, B.-Z., Deng, H.-J., Wu, G.-C., Deng, K., Chen, Y.-K., Liao, P., Qiu, J.-F., Lin, Y., Cai, X.-F., Wang, D.-Q., Hu, Y., Ren, J.-H., Tang, N., Xu, Y.-Y., Yu, L.-H., Mo, Z., Gong, F., Zhang, X.-L., … Huang, A.-L. (2020). Antibody responses to SARS-CoV-2 in patients with COVID-19. Nature Medicine, 26(6), 845–848. https://doi.org/10.1038/s41591-020-0897-1

Malik, Y. S., Sircar, S., Bhat, S., Sharun, K., Dhama, K., Dadar, M., Tiwari, R., & Chaicumpa, W. (2020). Emerging novel coronavirus (2019-nCoV)-current scenario, evolutionary perspective based on genome analysis and recent developments. The Veterinary Quarterly, 40(1), 68–76. https://doi.org/10.1080/01652176.2020.1727993

People’s Republic of China. (2020). Diagnosis and Treatment Protocol for COVID-19 (Trial Version 7).

Sanders, J. M., Monogue, M. L., Jodlowski, T. Z., & Cutrell, J. B. (2020). Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19): A Review. JAMA - Journal of the American Medical Association, 323(18), 1824–1836. https://doi.org/10.1001/jama.2020.6019

Schwartz, D. A., & Graham, A. L. (2020). Potential Maternal and Infant Outcomes from (Wuhan) Coronavirus 2019-nCoV Infecting Pregnant Women: Lessons from SARS, MERS, and Other Human Coronavirus Infections. Viruses, 12(2). https://doi.org/10.3390/v12020194

Shin, H.-S., Kim, Y., Kim, G., Lee, J. Y., Jeong, I., Joh, J.-S., Kim, H., Chang, E., Sim, S. Y., Park, J.-S., & Lim, D.-G. (2019). Immune Responses to Middle East Respiratory Syndrome Coronavirus During the Acute and Convalescent Phases of Human Infection. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America, 68(6), 984–992. https://doi.org/10.1093/cid/ciy595

United States of America. (2020). Fecal Microbiota for Transplantation: New Safety Information - Regarding Additional Protections for Screening Donors for COVID-19 and Exposure to SARS-CoV-2 and Testing for SARS-CoV-2.

van Doremalen, N., Bushmaker, T., Morris, D. H., Holbrook, M. G., Gamble, A., Williamson, B. N., Tamin, A., Harcourt, J. L., Thornburg, N. J., Gerber, S. I., Lloyd-Smith, J. O., de Wit, E., & Munster, V. J. (2020). Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1. The New England Journal of Medicine, 382(16), 1564–1567. https://doi.org/10.1056/NEJMc2004973

Wang, C.-Z., & Chi, C.-W. (2003). [The biological characteristics of SARS virus and its related coronaviruses]. Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao Acta Biochimica et Biophysica Sinica, 35(6), 495–502.

WHO. (2009). Infection-control measures for health care of patients with acute respiratory diseases in community settings. Trainer’s guide.

WHO. (2020a). Coronavirus: symptoms. Recuperado de https://www.who.int/health-topics/coronavirus#tab=tab_3

WHO. (2020b). Coronavirus disease 2019 (‎COVID-19)‎: situation report, 102. Recuperado de https://apps.who.int/iris/handle/10665/332055

WHO. (2020c). Coronavirus disease 2019 (‎COVID-19)‎: situation report, 38. Recuperado de https://apps.who.int/iris/handle/10665/331226

Woo, P. C. Y., Huang, Y., Lau, S. K. P., & Yuen, K.-Y. (2010). Coronavirus genomics and bioinformatics analysis. Viruses, 2(8), 1804–1820. https://doi.org/10.3390/v2081803

Wu, F., Zhao, S., Yu, B., Chen, Y.-M., Wang, W., Hu, Y., Song, Z.-G., Tao, Z.-W., Tian, J.-H., Pei, Y.-Y., Yuan, M.-L., Zhang, Y.-L., Dai, F.-H., Liu, Y., Wang, Q.-M., Zheng, J.-J., Xu, L., Holmes, E. C., & Zhang, Y.-Z. (2020). Complete genome characterisation of a novel coronavirus associated with severe human respiratory disease in Wuhan, China. https://www.biorxiv.org/content/10.1101/2020.01.24.919183v2

Xydakis, M. S., Dehgani-Mobaraki, P., Holbrook, E. H., Geisthoff, U. W., Bauer, C., Hautefort, C., Herman, P., Manley, G. T., Lyon, D. M., & Hopkins, C. (2020). Smell and taste dysfunction in patients with COVID-19. The Lancet. Infectious Diseases, 8, 243. https://doi.org/10.1016/S1473-3099(20)30293-0

Yang, M. (2020). Cell Pyroptosis, a Potential Pathogenic Mechanism of 2019-nCoV Infection. SSRN Electronic Journal. https://doi.org/10.2139/ssrn.3527420

Yang, N., & Shen, H.-M. (2020). Targeting the Endocytic Pathway and Autophagy Process as a Novel Therapeutic Strategy in COVID-19. International Journal of Biological Sciences, 16(10), 1724–1731. https://doi.org/10.7150/ijbs.45498

Yang, Y., Peng, F., Wang, R., Yange, M., Guan, K., Jiang, T., Xu, G., Sun, J., & Chang, C. (2020). The deadly coronaviruses: The 2003 SARS pandemic and the 2020 novel coronavirus epidemic in China. Journal of Autoimmunity, 109, 102434. https://doi.org/10.1016/j.jaut.2020.102434

Zeng, Q., Langereis, M. A., van Vliet, A. L. W., Huizinga, E. G., & de Groot, R. J. (2008). Structure of coronavirus hemagglutinin-esterase offers insight into corona and influenza virus evolution. Proceedings of the National Academy of Sciences of the United States of America, 105(26), 9065–9069. https://doi.org/10.1073/pnas.0800502105

Downloads

Published

06/09/2020

How to Cite

MENDES, S. C. .; OLIVEIRA, J. V. de .; FERRARI, A. C. .; GOIS, K. C. de .; NICOLAU, L. D. .; OLIVEIRA, M. P. de .; MENEZES-RODRIGUES, F. S. .; PACKER, M. L. T. .; FONSECA, F. L. A. .; GEHRKE, F. de S. . COVID-19: viral characterization, pathophysiology and prevention. Research, Society and Development, [S. l.], v. 9, n. 9, p. e750997768, 2020. DOI: 10.33448/rsd-v9i9.7768. Disponível em: https://rsdjournal.org/index.php/rsd/article/view/7768. Acesso em: 23 may. 2025.

Issue

Vol. 9 No. 9

Section

Review Article

License

Copyright (c) 2020 Sheila Chagas Mendes; Juliane Vismari de Oliveira; Ana Carolina Ferrari; Katharyna Cardoso de Gois; Lucas Duarte Nicolau; Marcelo Pires de Oliveira; Francisco Sandro Menezes-Rodrigues; Maria Lúcia Tomanik Packer; Fernando Luiz Affonso Fonseca; Flávia de Sousa Gehrke

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors who publish with this journal agree to the following terms:

1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.

2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.

3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.